期刊文献+

住院扩张型心肌病患者长期随访超声心动图预后分析 被引量:6

Long-term echocardiographic prognosis in hospitalized patients with dilated cardiomyopathy
原文传递
导出
摘要 目的 本研究分析住院扩张型心肌病(DCM)患者长期随访中超声心动图指标恢复及复发情况.方法 入选2009年1月至2013年12月在阜外医院心力衰竭监护病房住院且复查超声心动图的DCM患者,随访至2015年12月或发生全因死亡或心脏移植.定义随访时左心室射血分数(LVEF)≥50%(较基线提高≥10%)且左心室舒张末期内径(LVEDD)≤55 mm(较基线缩小≥5 mm)为超声心动图指标恢复.定义恢复患者LVEF≤40%或LVEDD≥60 mm为超声心动图指标复发.结果 有465例DCM患者纳入本研究,超声心动图中位随访33(15,49)个月后有134例超声心动图指标恢复(恢复率28.8%),其LVEF由基线时(30.8±6.0)%明显提高至首次恢复时(55.7±4.3)%,LVEDD由(64.5 ±5.6)mm缩小至(51.0 ±3.1)mm(P均<0.01),中位恢复时间为12(6,21)个月.入院时心力衰竭症状病史、LVEDD、右心室前后径、血钠浓度及出院时收缩压水平是恢复的独立预测因素(P均<0.01).134例恢复患者中有103例恢复后复查超声心动图,中位随访26(16.43)个月,其中16例超声心动图指标复发(复发率15.5%),其LVEF从首次恢复时(56.9±3.8)%明显降低至首次复发时(36.7±5.7)%,LVEDD从(52.3±2.4) mm增大至(64.6 ±6.1)mm(P均<0.01),中位复发时间为25(8,32)个月,未发现复发的独立预测因素.临床中位随访42(17,58)个月,恢复患者的无心脏移植存活率明显高于未恢复患者(P<0.01).结论 住院DCM患者出院后随访3年时约30%患者超声心动图指标恢复,其长期预后优于未恢复患者.恢复患者恢复后继续随访2年时约16%患者超声心动图指标复发,未发现复发的独立预测因素. Objective To investigate the echocardiographic recovery and relapse at long-term follow-up in hospitalized patients with dilated cardiomyopathy(DCM).Methods Patients with DCM hospitalized in Heart Failure Care Unit,Fuwai Hospital between 2009-01 and 2013-12 who had repeat echocardiography(ECHO)after discharge were followed to 2015-12 or until all-cause death or cardiac transplantation.Recovery was defined as an absolute increase in left ventricular ejection fraction(LVEF)≥10%to a level of≥50%and decrease in left ventricular end-diastolic diameter(LVEDD)≥5 mm to a level of≤55 mm on follow-up and relapse was defined as LVEF≤40%or LVEDD≥60 mm after initial recovery.Results A total of 465 patients with DCM were enrolled in this analysis.After a median follow-up of 33(15,49)months with repeat ECHO,134 patients(28.8%)achieved recovery,showing a significant increase in LVEF from(30.8±6.0)%at baseline to(55.7±4.3)%at initial recovery and decrease in LVEDD from(64.5±5.6)mm to(5 1.0±3.1)mm(both P<0.01),with median recovery duration of 12(6,21)months.Symptom duration of heart failure,LVEDD,right ventricular diameter,serum sodium on admission and systolic blood pressure on discharge were found to be independent predictors of recovery(all P<0.01).Among 134 recovered patient,103 had repeat ECHO after initial recovery,with a median furthe follow up duration of 26(16.43)months,of whom 16(15.5%)suffered relapse,showing a significant decrease in LVEF from(56.9±3.8)%at initial recovery to(36.7±5.7)%at initial relapse and increase in LVEDD from(52.3±2.4)mm to(64.6±6.1)mm(both P<0.01),with a median relapse duration of 25(8,32)months.There was no independent predictor of relapse.Recovered patients had a significant higher transplant-free survival rate than those without recovery at a clinical follow-up duration of 42(17,58)months(P<0.01).Conclusion About 30%hospitalized patients with DCM can achieve recovery at 3-year follow-up after discharge,which was associated with better long-term prognosis.Moreover,around 16%patients with recovery may suffer a relapse after initial recovery though no predictor was found.
作者 邹长虹 黄燕 周琼 张荣成 安涛 吕蓉 张宇辉 张健 Zou Changhong;Huang Yan;Zhou Qiong;Zhang Rongcheng;An Tao;Lyu Rong;Zhang Yuhui;Zhang Jian(Heart Failure Center,Fuwai Hospital,National Center far Cardiovascular Diseases,Chinese Academy of Medical Sciences,167 Beilishi Road,Beijing 100037,China)
出处 《中华心力衰竭和心肌病杂志(中英文)》 2018年第2期79-85,共7页 Chinese Journal of Heart Failure and Cardiomyopathy
基金 “十二·五”国家科技支撑计划项目(2011BAI11B02).
关键词 心肌病 扩张型 预后 Cardiomyopathy,dilated Prognosis
  • 相关文献

参考文献4

二级参考文献107

  • 1王志民,邹玉宝,宋雷,马爱群,刘唐威,谷惠敏,卢赛兰,武鹏翥,孙兆明,何国宝,张卫,张颖,沈丽,蔡玉岭,甄一松,刘延玲,惠汝太.超声心动图检查调查8080例成人肥厚型心肌病患病率[J].中华心血管病杂志,2004,32(12):1090-1094. 被引量:60
  • 2张寄南,曹克将.肥厚型心肌病诊断与治疗——美国心脏病学学会/欧洲心脏病学学会、美国心脏病协会专家共识导读[J].中华心血管病杂志,2005,33(6):491-494. 被引量:35
  • 3廖玉华,袁璟.扩张型心肌病分子免疫治疗靶点的研究进展[J].中华医学杂志,2006,86(17):1158-1160. 被引量:8
  • 4心肌病诊断与治疗建议[J].中华心血管病杂志,2007,35(1):5-16. 被引量:556
  • 5Richardson P,McKenna W,Bristow M,et al.Report of the 1995 World Health Organization/International Society and Federation of Cardiology Task Force on the Definition and Classification of cardiomyopathies.Circulation,1996,93(5):841-842.
  • 6Maron BJ,Towbin JA,Thiene G,et al.Contemporary definitions and classification of the cardiomyopathies:an American Heart Association Scientific Statement from the Council on Clinical Cardiology,Heart Failure and Transplantation Committee; Quality of Care and Outcomes Research and Functional Genomics and Translational Biology Interdisciplinary Working Groups; and Council on Epidemiology and Prevention.Circulation,2006,113(14):1807-1816.
  • 7Elliott PM,Mckenna WJ.Natural history of hypertrophic cardiomyopathy.[EB/OL][2006-8-2].http://www.utdol.com/utd/content/topic.do?topicKey=myoperic/11502&type=A&selectedTitle=4~58.
  • 8Cooper LT.Definition and classification of the cardiomyopathies.[EB/OL][2006-8-2].http://www.utdol.com.beckerproxy.wustl.edu/applica.../6085&type=A&selectedTitle=2~5.
  • 9McKenna WJ.Genetics of hypertrophic cardiomyopathy.[EB/OL][2006-8-2].http://www.utdol.com/utd/content/topic.do?topicKey=myoperic/9673&type=A&selectedTitle=3~58.
  • 10Poliac LC,Barron ME,Maron BJ.Hypertrophic cardiomyopathy.Anesthesiology,2006,104(1):183-192.

共引文献5247

同被引文献31

引证文献6

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部